Evidence map›Paper›PMID 28901488›Full record

ArticleMolecular medicine reports2017

The role of fructose‑1,6‑bisphosphatase 1 in abnormal development of ovarian follicles caused by high testosterone concentration.

Tao Liu, Han Zhao, Jianfeng Wang, Xin Shu, Yuan Gao, Xiaoli Mu, Fei Gao, Hongbin Liu

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Rehmannioside D mitigates disease progression in rats with experimental-induced diminished ovarian reserveThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tao LiuCenter for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250001, P.R. China.
Han ZhaoCenter for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250001, P.R. China.
Jianfeng WangCenter for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250001, P.R. China.
Xin ShuCenter for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250001, P.R. China.
Yuan GaoCenter for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250001, P.R. China.
Xiaoli MuCenter for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250001, P.R. China.
Fei GaoState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, P.R. China.
Hongbin LiuCenter for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250001, P.R. China.
Shandong University · CNShandong Provincial Hospital · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to identify the molecular mechanisms underlying the effects of the fructose‑1,6‑bisphosphatase 1 (FBP1) signaling pathway within normal follicle development and in hyperandrogenism‑induced abnormal follicle growth. To achieve this, murine primary follicles, granulosa cells (GCs) and theca‑interstitial cells (TICs) were isolated, cultured in vitro and treated with a high concentration of androgens. A concentration of 1x10‑5 mol/l testosterone was considerable to induce hyperandrogenism by MTT assay. All cells were divided into four groups, as follows: Control group, testosterone group, androgen receptor antagonist‑flutamide group and flutamide + testosterone group. Flutamide was used in the present study as it blocks the effects of the androgen receptor. The mRNA expression levels of FBP1 were detected using reverse transcription‑quantitative polymerase chain reaction. The expression levels and localization of FBP1 were analyzed by western blot analysis and immunofluorescence staining. The experimental results demonstrated that androgen presence stimulated follicle development, whereas excessive testosterone inhibited development. FBP1 was identified as being mainly expressed in follicles; FBP1 protein was significantly expressed in GCs of the 14‑day‑cultured follicle, as well as in the cytoplasm and nuclei of GCs and TICs in vitro. Testosterone increased FBP1 expression during a specific range of testosterone concentrations. Testosterone increased the expression of FBP1 within GCs. Furthermore, FBP1 and phosphoenolpyruvate carboxykinase 1 (PCK1) mRNA expression was increased in GCs treated with testosterone, whereas forkhead box protein O1 (FOXO1) and peroxisome proliferator‑activated receptor γ coactivator‑1α mRNA expression was significantly decreased in the testosterone group. In TICs, testosterone and flutamide inhibited the mRNA expression levels of FOXO1 and glucose‑6‑phosphatase enzyme, and promoted the expression of PCK1. These results suggested that the FBP1 signaling pathway may serve an important role in normal follicle growth and hyperandrogenism‑induced abnormal development, which may be associated with abnormal glucose metabolism induced by high concentrations of testosterone.

Indexed as

Gene Expression Regulation, DevelopmentalAndrogen AntagonistsAnimalsFemaleFlutamideForkhead Box Protein O1Fructose-BisphosphataseGlucoseGranulosa CellsHyperandrogenismMiceModels, BiologicalOvarian FolliclePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhosphoenolpyruvate Carboxykinase (GTP)Primary Cell CultureAndrogen AntagonistsFlutamideForkhead Box Protein O1Foxo1 protein, mouseFructose-BisphosphataseGlucosePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhosphoenolpyruvate Carboxykinase (GTP)Ppargc1a protein, mouseReceptors, AndrogenRNA, MessengerTestosterone

Identifiers

PMID28901488
PMCPMC5865816
OpenAlexW2754864427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.